India Hiv/Aids Alliance U/S 25 Profile
Key Indicators
- Company Age 25 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -14.61%
(FY 2023)
- Profit 361.95%
(FY 2023)
- Ebitda 16.12%
(FY 2023)
- Net Worth 22.56%
(FY 2023)
- Total Assets -2.46%
(FY 2023)
About India Hiv/Aids Alliance U/S 25
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Shahabuddin Quraishi, Kapil Kaul, Meenakshi Sharma, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85310DL1999NPL098570
- Company No.
098570
- Company Classification
Public Not For Profit Company
- Incorporation Date
25 Feb 1999
- Date of AGM
18 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at India Hiv/Aids Alliance U/S 25?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shahabuddin Quraishi  | Director | 01-Apr-2015 | Current |
| Kapil Kaul | Director | 30-Apr-2021 | Current |
| Meenakshi Sharma | Director | 11-Mar-2024 | Current |
| Sanjay Patra | Director | 25-Apr-2013 | Current |
| Madhu Nath | Director | 02-Feb-2016 | Current |
Financial Performance and Corporate Structure Insights of India Hiv/Aids Alliance U/S 25.
India Hiv/Aids Alliance U/S 25, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.61% decrease. The company also saw a substantial improvement in profitability, with a 361.95% increase in profit. The company's net worth Soared by an impressive increase of 22.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of India Hiv/Aids Alliance U/S 25?
Unlock access to India Hiv/Aids Alliance U/S 25's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Innovative Change Collaborative Services Private LimitedActive 9 years 4 monthsSanjay Patra is a mutual person
- South Asia Risk Management Centre Private LimitedActive 9 years 9 months
Sanjay Patra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at India Hiv/Aids Alliance U/S 25?
Unlock and access historical data on people associated with India Hiv/Aids Alliance U/S 25, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of India Hiv/Aids Alliance U/S 25, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped India Hiv/Aids Alliance U/S 25's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
